Manufacturing

Izaskun Elorza, MD, is the senior medical director for cell and gene therapy at Parexel.

Articles

Finding specific solutions to overcome uncertainty has led to the evolution of a new clinical trial research environment.

Evolution to a New Clinical Research Environment for Cellular Therapies

Inceptor Bio and the University of Minnesota aim to build a novel iPSC platform to accelerate cell therapy drug development.

Inceptor Bio Collaborates with University of Minnesota to Develop Cell Therapy Platform

Jennifer Markarian is manufacturing editor of BioPharm International.

Precompetitive consortiums seek solutions to industry-wide challenges.


Coming Together to Enable Cell  and Gene Therapy Manufacturing

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

AGC Biologics Adds Viral Vector Suspension Technology at New US Campus

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Outsourcing partners are ready to fill the market need for greater cell therapies capacities.

Scaling Up Cell Therapies Capacity

Feliza Mirasol is the science editor for 

Complex hurdles complicate the development of emerging therapies.

Emerging Therapies Face Development Hurdles

Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.

Emerging Plant-based Platform for Biomanufacturing

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Some progress has been made, but improvements are needed when harvesting cells for cell therapies.

Automating Cell Harvesting for Cell Therapies

The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.

Manufacturing, Cell Therapies